William Plovanic
Stock Analyst at Canaccord Genuity
(2.97)
# 1,292
Out of 5,182 analysts
184
Total ratings
38.18%
Success rate
1.3%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $87 → $85 | $84.15 | +1.01% | 31 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $109 → $71 | $62.07 | +14.39% | 16 | Apr 23, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $10 | $7.72 | +29.53% | 11 | Apr 14, 2026 | |
| STIM Neuronetics | Maintains: Buy | $7 → $3 | $1.68 | +78.57% | 5 | Mar 19, 2026 | |
| HTFL HeartFlow | Maintains: Buy | $40 → $43 | $30.44 | +41.26% | 5 | Mar 19, 2026 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $7 | $4.63 | +51.19% | 7 | Mar 9, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $122.35 | +61.83% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $189.56 | +129.48% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $29.28 | +81.01% | 13 | Feb 18, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $61.57 | +54.30% | 10 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $48 | $37.76 | +27.12% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $35 | $20.36 | +71.91% | 7 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $147 → $148 | $110.93 | +33.42% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $21.18 | +41.64% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $11.10 | +62.16% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $94.87 | -5.13% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $91.26 | +10.67% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.09 | +48.66% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $329.89 | -13.91% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.90 | +129.36% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.27 | +844.88% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $68.58 | +2.07% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $25.67 | +86.99% | 5 | Aug 3, 2023 |
Edwards Lifesciences
Apr 24, 2026
Maintains: Hold
Price Target: $87 → $85
Current: $84.15
Upside: +1.01%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $109 → $71
Current: $62.07
Upside: +14.39%
CVRx, Inc.
Apr 14, 2026
Maintains: Buy
Price Target: $10
Current: $7.72
Upside: +29.53%
Neuronetics
Mar 19, 2026
Maintains: Buy
Price Target: $7 → $3
Current: $1.68
Upside: +78.57%
HeartFlow
Mar 19, 2026
Maintains: Buy
Price Target: $40 → $43
Current: $30.44
Upside: +41.26%
TriSalus Life Sciences
Mar 9, 2026
Maintains: Buy
Price Target: $7
Current: $4.63
Upside: +51.19%
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $122.35
Upside: +61.83%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $189.56
Upside: +129.48%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $29.28
Upside: +81.01%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $61.57
Upside: +54.30%
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $37.76
Upside: +27.12%
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $20.36
Upside: +71.91%
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $110.93
Upside: +33.42%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $21.18
Upside: +41.64%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $11.10
Upside: +62.16%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $94.87
Upside: -5.13%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $91.26
Upside: +10.67%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.09
Upside: +48.66%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $329.89
Upside: -13.91%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.90
Upside: +129.36%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.27
Upside: +844.88%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $68.58
Upside: +2.07%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $25.67
Upside: +86.99%